The Microdose GLP-1Rx Program will offer low-dose GLP-1 prescriptions combined with behavioral coaching, clinical monitoring and medication management.

The new law bans the use of AI for mental health and therapeutic decision-making, but states it can be used for ...

Global healthcare venture fund OrbiMed announced it raised $1.86 billion for Healthcare Royalty and Credit Fund V to invest in growth-oriented companies.

The company began trading on the NYSE in May and saw an increase in its stock price upon the news of its second quarter earnings.

Clinicians need to have integrity with how they present AI tools to their teams, focusing on how those tools can solve problems, says Josh Wymer, chief health information and data strategy officer at ...